First Trial to Prove a Diet Supplement Can Prevent Hereditary Cancer

A promising clinical trial result showing that some Lynch Syndrome associated cancer risks can be reduced by over 60%! This study showed that a regular dose of resistant starch taken for an average of 2 years can significantly reduce cancer risks, particularly in pancreatic, gastric, esophageal and other upper GI cancers that are difficult to diagnose and are often not caught until an advanced stage.

A new study led by experts at the Universities of New Castle and Leeds in the UK was the first trial to prove a dietary supplement can prevent hereditary cancer.

“An international trial - known as CAPP2 – involved almost 1000 patients with Lynch syndrome from around the world and revealed that a regular dose of resistant starch, also known as fermentable fibre, taken for an average of two years, did not affect cancers in the bowel but did reduce cancers in other parts of the body by more than half. This effect was particularly pronounced for upper gastrointestinal cancers including oesophageal, gastric, biliary tract, pancreatic and duodenum cancers.

This study is a planned double-blind 10-year follow-up, supplemented with comprehensive national cancer registry data for up to 20 years in 369 of the participants.”

According to Professor John Mathers of Human Nutrition at Newcastle University, their study showed resistant starch reduces a range of cancer by over 60%. “This is important as cancers of the upper GI tract are difficult to diagnose and often are not caught early on.”

Previous studies have found that individuals with Lynch Syndrome who take aspirin daily can reduce their cancer of the large bowel by 50%. Based on this new trial, NICE now recommends people at high genetic risk of cancer, including Lynch Syndrome, taking aspirin and resistant starch work.

Learn more about this trial and its amazing results: https://www.ncl.ac.uk/press/articles/latest/2022/07/dietsupplementcanpreventhereditarycancer/?fbclid=IwAR37kDYaVfronTaJJ7tqmQCDqN8e2epgREwsPtPy5_4WLj60KAIBsVqzDjY